Status
Conditions
Study type
Funder types
Identifiers
About
The purpose of the study is to evaluate the association between the number of circulating tumor cells and response to treatment in non small-cell lung cancer patients
Full description
In spite of technological advantages in diagnosis and treatment, lung cancer remains one of the most deadly malignant neoplasias. Moreover, there are no markers for monitoring response to treatment. The objective of the study is to associate the number of circulating tumor cells (CTC) before and after treatment and correlate it with tumor response rate, progression-free survival and overall survival.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Non-advanced disease
200 participants in 1 patient group
Loading...
Central trial contact
Oscar Arrieta, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal